Inclusion Criteria:  Patients with severe chronic pain (> 5 on numeric rating scale, NRS) for at least 6 months due to FBSS (PSPS T2) and suitable for treatment with DTM SCS according to the treating physician Age > 18 years Patient has been informed of the study procedures and has given written informed consent Patient willing to comply with study protocol including attending the study visits  Exclusion Criteria:  Expected inability of the patient to receive or properly operate the spinal cord stimulation system History of coagulation disorder, lupus erythematosus, diabetic neuropathy, rheumatoid arthritis, or morbus Bechterew Active malignancy Addiction to drugs, alcohol (>5 units per day) and/or medication Evidence of an active disruptive psychiatric disorder or other known condition that may impact perception of pain, compliance to the intervention, and/or ability to evaluate treatment outcome as determined by investigator Immune deficiency (e.g. HIV positive, immunosuppressive treatment) Life expectancy < 1 year Local infection or any other skin disorder at site of incision Pregnancy Other implanted active medical device